TAK

Takeda Pharmaceutical Company Limited
D

TAK

15.185
USD
0.22
(1.44%)
مغلق
حجم التداول
188,125
الربح لكل سهم
143
العائد الربحي
4.13
P/E
34
حجم السوق
47,966,560,493
أصول ذات صلة
AZN
AZN
1.720
(2.38%)
73.950 USD
BMY
BMY
-1.750
(-2.94%)
57.830 USD
GILD
GILD
0.450
(0.40%)
112.380 USD
GSK
GSK
1.345
(3.57%)
38.980 USD
JNJ
JNJ
4.470
(2.88%)
159.810 USD
LLY
LLY
-28.72
(-3.51%)
788.94 USD
MRK
MRK
-0.220
(-0.25%)
86.370 USD
NVO
NVO
-1.090
(-1.60%)
67.120 USD
NVS
NVS
1.540
(1.39%)
112.300 USD
PFE
PFE
-0.385
(-1.56%)
24.290 USD
SNY
SNY
0.720
(1.34%)
54.610 USD
المزيد
الأخبار المقالات

العنوان: Takeda Pharmaceutical Company Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.